Nasdaq: RKDA

Arcadia Biosciences, Inc. (RKDA)

Arcadia Biosciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker RKDA. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
RKDA
Exchange
Nasdaq
SEC CIK
1469443
Official filings
SEC EDGAR

Research RKDA

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Arcadia Biosciences, Inc.'s stock ticker?

Arcadia Biosciences, Inc. trades under the ticker symbol RKDA on Nasdaq. Its SEC Central Index Key (CIK) is 1469443.

Where can I read Arcadia Biosciences, Inc.'s SEC filings?

The RKDA SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Arcadia Biosciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze RKDA's financial statements?

The RKDA Financials page shows Arcadia Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does RKDA compare with its peers and the market?

The RKDA Peer Comparison page lines Arcadia Biosciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.